Page 49 - ARNM-1-1

Advances in Radiotherapy
& Nuclear Medicine CCRT plus nimotuzumab for cervical cancer

radiotherapy in patients with locoregionally advanced Duodenal and other gastrointestinal toxicity in cervical and
nasopharyngeal carcinoma. Onco Targets Ther, 8: 3383–3390. endometrial cancer treated with extended-field intensity
modulated radiation therapy to paraaortic lymph nodes. Int
https://doi.org/10.2147/OTT.S93238
J Radiat Oncol Biol Phys, 85: 1262–1268.
23. You B, Brade A, Magalhaes JM, et al., 2011, A dose-escalation https://doi.org/10.1016/j.ijrobp.2012.10.004
phase I trial of nimotuzumab, an antibody against the
epidermal growth factor receptor, in patients with advanced 30. Lee J, Lin JB, Chang CL, et al., 2017, Prophylactic lower
solid malignancies. Invest New Drugs, 29: 996–1003. para-aortic irradiation using intensity-modulated
radiotherapy mitigates the risk of para-aortic recurrence
https://doi.org/10.1007/s10637-010-9444-0
in locally advanced cervical cancer: A 10-year institutional
24. Crombet T, Osorio M, Cruz T, et al., 2004, Use of the experience. Gynecol Oncol, 146: 20–26.
humanized anti-epidermal growth factor receptor https://doi.org/10.1016/j.ygyno.2017.04.016
monoclonal antibody h-R3 in combination with
radiotherapy in the treatment of locally advanced head and 31. Choi S, Hsu ICJ, 2018, Cervial cancer. In: Hansen EK, Roach
neck cancer patients. J Clin Oncol, 22: 1646–1654. M, (eds). Handbook of Evidence-Based Radiation Oncology.
3 ed. New York: Springer International Publishing, p623–
rd
https://doi.org/10.1200/JCO.2004.03.089 644.
25. Hasselle MD, Rose BS, Kochanski JD, et al., 2011, Clinical 32. Wang W, Zhang F, Hu K, et al., 2018, Image-guided, intensity-
outcomes of intensity-modulated pelvic radiation therapy modulated radiation therapy in definitive radiotherapy
for carcinoma of the cervix. Int J Radiat Oncol Biol Phys, 80: for 1433 patients with cervical cancer. Gynecol Oncol, 151:
1436–1445. 444–448.
https://doi.org/10.1016/j.ijrobp.2010.04.041 https://doi.org/10.1016/j.ygyno.2018.09.024
26. Yu C, Zhu W, Ji Y, et al., 2015, A comparative study of 33. Pötter R, Georg P, Dimopoulos JCA, et al., 2011, Clinical
intensity-modulated radiotherapy and standard radiation outcome of protocol based image (MRI) guided adaptive
field with concurrent chemotherapy for local advanced brachytherapy combined with 3D conformal radiotherapy
cervical cancer. Eur J Gynaecol Oncol, 36: 278–282. with or without chemotherapy in patients with locally
27. Gandhi AK, Sharma DN, Rath GK, et al., 2013, Early advanced cervical cancer. Radiother Oncol, 100: 116–123.
clinical outcomes and toxicity of intensity modulated versus https://doi.org/10.1016/j.radonc.2011.07.012
conventional pelvic radiation therapy for locally advanced
cervix carcinoma: A prospective randomized study. Int J 34. Yoon HI, Cha J, Keum KC, et al., 2015, Treatment outcomes
Radiat Oncol Biol Phys, 87: 542–548. of extended-field radiation therapy and the effect of
concurrent chemotherapy on uterine cervical cancer with
https://doi.org/10.1016/j.ijrobp.2013.06.2059 para-aortic lymph node metastasis. Radiat Oncol, 10: 18.
28. Erpolat OP, Alco G, Caglar HB, et al., 2014, Comparison https://doi.org/10.1186/s13014-014-0320-5
of hematologic toxicity between 3DCRT and IMRT
planning in cervical cancer patients after concurrent 35. Ng BH, Rozita A, Adlinda A, et al., 2015, Extended field
radiotherapy with or without chemotherapy in patients
chemoradiotherapy: A national multi-center study. Eur J with cervical cancer and positive para-aortic lymph nodes:
Gynaecol Oncol, 35: 62–66.
A single institution retrospective review. Asian Pac J Cancer
https://doi.org/10.12892/ejgo23912014 Prev, 16: 3827–3833.
29. Poorvu PD, Sadow CA, Townamchai K, et al., 2013, https://doi.org/10.7314/apjcp.2015.16.9.3827

Volume 1 Issue 1 (2023) 8 https://doi.org/10.36922/arnm.0408